EUVIMEDEUVIMED entdecken
Crossref

Study of serum monocyte chemoattractant protein-1 as a marker of disease activity in rheumatoid arthritis patients

MosabMohammed Adel, MagdyAbd El-Aziz El-Zohairy, AnnaNashait Abou-Raya, AkramAbd El-Monem Degady, EmanHassan El-Said

Egyptian Journal of Obesity, Diabetes and Endocrinology · 2015

DOI: 10.4103/2356-8062.178338 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Egyptian Journal of Obesity, Diabetes and Endocrinology, 2015. Verfasst von MosabMohammed Adel und 4 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

IntroductionRheumatoid arthritis (RA) is a chronic systemic disease that primarily targets the synovium, leading to synovial inflammation and proliferation, loss of articular cartilage, and erosion of juxta-articular bone.ObjectiveThe aim of the work was to assess the role of serum monocyte chemoattractant protein-1 (MCP-1) as a marker of disease activity in RA and its correlation with different disease parameters.Patients and methodsWe assessed serum MCP-1 level in 40 RA patients and 20 age-matched and sex-matched healthy controls. We also assessed different clinical and laboratory disease parameters in RA patients - namely, swollen joint count, tender joint count, erythrocyte sedimentation rate, C-reactive protein (CRP), rheumatoid factor, anti-cyclic citrullinated peptide (ACCP), and 28-joint Disease Activity Score (DAS-28) (CRP). We correlated serum MCP-1 with disease activity and different disease parameters.ResultsSerum MCP-1 was significantly higher (P = 0.001) in the patient group (mean = 414, SD = 508.97) than in the control group (mean = 77.25, SD = 16.58). Serum level also correlated significantly with rheumatoid factor (P = 0.004), swollen joint count (P = 0.004), and with DAS-28 CRP score (0.034). There was no significant correlation between MCP-1 and tender joint count, erythrocyte sedimentation rate, CRP, or radiographic changes.ConclusionSerum MCP-1 is a useful biomarker in monitoring RA activity.

Zitieren

APA

Adel, M., El-Zohairy, M. E., Abou-Raya, A., Degady, A. E., & El-Said, E. (2015). Study of serum monocyte chemoattractant protein-1 as a marker of disease activity in rheumatoid arthritis patients. Egyptian Journal of Obesity, Diabetes and Endocrinology. https://doi.org/10.4103/2356-8062.178338

Vancouver

Adel M, El-Zohairy ME, Abou-Raya A, Degady AE, El-Said E. Study of serum monocyte chemoattractant protein-1 as a marker of disease activity in rheumatoid arthritis patients. Egyptian Journal of Obesity, Diabetes and Endocrinology. 2015. doi:10.4103/2356-8062.178338

BibTeX
@article{Adel2015,
  author = {Adel, MosabMohammed and El-Zohairy, MagdyAbd El-Aziz and Abou-Raya, AnnaNashait and Degady, AkramAbd El-Monem and El-Said, EmanHassan},
  title = {Study of serum monocyte chemoattractant protein-1 as a marker of disease activity in rheumatoid arthritis patients},
  journal = {Egyptian Journal of Obesity, Diabetes and Endocrinology},
  year = {2015},
  doi = {10.4103/2356-8062.178338}
}
Kostenlos starten →